Stockreport

Longeveron to Present at Biotech Showcase 2025

Longeveron Inc. - Class A Common stock  (LGVN) 
PDF MIAMI, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for [Read more]